4 stories mentioning MRAM
Every FINWIRES story that references MRAM, newest first.
Glen Hawk, Director, on May 15, 2026, sold 48,563 shares in Everspin Technologies (MRAM) for $1,843,109. Following the Form 4 filing with the SEC, Hawk has control over a total of 39,551 common shares of the company, with 39,551 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1438423/000162828026035746/xslF345X05/wk-form4_1778886210.xml
Darin G Billerbeck, Director, on May 11, 2026, sold 30,000 shares in Everspin Technologies (MRAM) for $1,114,800. Following the Form 4 filing with the SEC, Billerbeck has control over a total of 124,073 common shares of the company, with 124,073 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1438423/000162828026034647/xslF345X05/wk-form4_1778704755.xml
Sanjeev Aggarwal, Director, President and CEO, on May 04, 2026, sold 28,459 shares in Everspin Technologies (MRAM) for $557,227. Following the Form 4 filing with the SEC, Aggarwal has control over a total of 819,422 common shares of the company, with 819,422 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1438423/000162828026030750/xslF345X05/wk-form4_1778016363.xml
Avalyn Pharma (AVLN), a clinical-stage drugmaker, said late Wednesday it has priced its upsized initial public offering of about 16.7 million shares at $18.00 apiece, targeting gross proceeds of about $300 million.Shares soared in their trading debut on Nasdaq, up over 50% at about $27.44 in afternoon trading, with intraday trading volume of over 3.65 million.Everspin Technologies (MRAM) reported Thursday an agreement with a US prime contractor to provide Toggle MRAM process technology and engineering services for United States Defense Industrial Base customers. The agreement is valued at $40.0 million and will run over two-and-a-half years.Shares surged 37% as intraday trading volume soared to over 12.6 million from a daily average of about 533,000.Viavi Solutions (VIAV) jumped 15% after its fiscal Q3 results and fiscal Q4 guidance exceeded market expectations.More than 15.1 million shares traded intraday, compared with a daily average of about 5.87 million.Price: $27.00, Change: $+9.00, Percent Change: +50.00%